These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 9575594

  • 1. [A trial of the use of the low-molecular heparin sulodexide in the therapy of diabetic nephropathy].
    Zalevskaia AG, Astamirova KhS, Karpova IA, Popova SG.
    Ter Arkh; 1998; 70(3):71-4. PubMed ID: 9575594
    [Abstract] [Full Text] [Related]

  • 2. [The efficacy of Sulodexide--a low-molecular heparin--in the therapy of diabetic nephropathy].
    Shestakova MV, Chugunova LA, Vorontsov AV, Dedov II.
    Ter Arkh; 1997; 69(6):34-7. PubMed ID: 9297270
    [Abstract] [Full Text] [Related]

  • 3. Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients.
    Sulikowska B, Olejniczak H, Muszyńska M, Odrowaz-Sypniewska G, Gaddi A, Savini C, Cicero AF, Laghi L, Manitius J.
    Am J Nephrol; 2006; 26(6):621-8. PubMed ID: 17191008
    [Abstract] [Full Text] [Related]

  • 4. [Sulodexide in the treatment of diabetic nephropathy].
    Rasovskiĭ BL, Tarasov AV, Trel'skaia NIu, Severina TI, Chernykh EF.
    Klin Med (Mosk); 1998; 76(7):40-2. PubMed ID: 9742778
    [Abstract] [Full Text] [Related]

  • 5. One year course of oral sulodexide in the management of diabetic nephropathy.
    Achour A, Kacem M, Dibej K, Skhiri H, Bouraoui S, El May M.
    J Nephrol; 2005; 18(5):568-74. PubMed ID: 16299683
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of low-dose oral sulodexide in the management of diabetic nephropathy.
    Blouza S, Dakhli S, Abid H, Aissaoui M, Ardhaoui I, Ben Abdallah N, Ben Brahim S, Ben Ghorbel I, Ben Salem N, Beji S, Chamakhi S, Derbel A, Derouiche F, Djait F, Doghri T, Fourti Y, Gharbi F, Jellouli K, Jellazi N, Kamoun K, Khedher A, Letaief A, Limam R, Mekaouer A, Miledi R, Nagati K, Naouar M, Sellem S, Tarzi H, Turki S, Zidi B, Achour A, DAVET (Diabetic Albuminuria Vessel Tunisia Study Investigators).
    J Nephrol; 2010; 23(4):415-24. PubMed ID: 20175052
    [Abstract] [Full Text] [Related]

  • 9. [The prognosis and control of the efficacy of heparin therapy in patients with diabetic glomerulosclerosis].
    Pyrig LA, Lapchinskaia II, Belitskaia GA, Lezhen TI, Iakovenko AM, Ishchenko VM, Fedorova NE.
    Klin Med (Mosk); 1996; 74(2):32-5. PubMed ID: 8772099
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin.
    Lewis EJ, Xu X.
    Diabetes Care; 2008 Feb; 31 Suppl 2():S202-7. PubMed ID: 18227486
    [Abstract] [Full Text] [Related]

  • 13. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy.
    Azadbakht L, Shakerhosseini R, Atabak S, Jamshidian M, Mehrabi Y, Esmaill-Zadeh A.
    Eur J Clin Nutr; 2003 Oct; 57(10):1292-4. PubMed ID: 14506491
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The kidney as a target organ in diabetic patients with arterial hypertension].
    Viberti G.
    Drugs; 2003 Oct; 63 Spec No 1():31-7. PubMed ID: 12708880
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.